Zymeworks Inc reports results for the quarter ended in June - Earnings Summary

Zymeworks

10/08/2023 22:57

* Zymeworks Inc  ZYME.OQ  reported a quarterly adjusted loss
of 76
cents​​ per share for the quarter ended in June. The mean
expectation of seven analysts for the quarter was for a loss
of 47 cents per share.
    * Revenue rose 28.7% to $7.00 million from a year ago;
analysts
expected $12.36 million. 
    * Zymeworks Inc's reported EPS for the quarter was a loss
of 76
cents​.
    * The mean earnings estimate of analysts had risen by
about 11.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Zymeworks Inc shares had fallen by 10.9% this quarter and
lost 2.0% so far this year.
    * The company reported a quarterly loss of $51.15 million.
    * Wall Street's median 12-month price target for Zymeworks
Inc is
$14.10 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 10 at 09:57 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.47          -0.76          Missed
 Mar. 31 2023      -0.54          -0.36          Beat
 Dec. 31 2022      4.84           4.65           Missed
 Sep. 30 2022      -0.92          -0.72          Beat